Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 6/20 | 0.49 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.43 |
| ▸ | NT5E | P21589 | 10/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.42 |
| ▸ | PNP | P00491 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22700162 | 0.87 | PDE2A (0.46) | PDE2ANT5EADORA3 | |
| SCHEMBL22700332 | 0.87 | PDE2A (0.57) | PDE2AADORA2AADORA2BNT5EPDE4D | |
| SCHEMBL19974448 | 0.86 | ADORA2A (0.55) | PDE2AADORA2AADORA2BNT5EPDE4D | |
| SCHEMBL19979067 | 0.79 | LMNA (0.40) | ADORA2ANT5ELMNATP53ADORA3 | |
| SCHEMBL22700153 | 0.79 | PDE2A (0.44) | PDE2ANT5EPDE4D | |
| SCHEMBL19974417 | 0.78 | PDE2A (0.51) | PDE2AADORA2ANT5E | |
| SCHEMBL22700164 | 0.77 | PDE2A (0.52) | PDE2ANT5EADORA3 | |
| SCHEMBL19974427 | 0.76 | ADORA2A (0.68) | PDE2AADORA2AADORA2BNT5EPDE4D | |
| SCHEMBL19978932 | 0.76 | PDE2A (0.49) | PDE2AADORA2ANT5EADORA3 | |
| SCHEMBL22700179 | 0.75 | NT5E (0.43) | ADORA2ANT5EADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512860-B1 | NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT | LCB PHARMA INC (CA) | 2020-11-25 | — | — | EP | disclosed |
| WO-2018049534-A1 | NUCLEOSIDE AND NUCLEOTIDE ANALOGUES BEARING A QUATERNARY ALL-CARBON STEREOGENIC CENTER AT THE 2' POSITION AND METHODS OF USE AS A CARDIOPROTECTIVE AGENT | LCB PHARMA INC. (CA) | 2018-03-22 | — | — | WO | disclosed |